Literature DB >> 22189822

Molecular epidemiology of HIV in two highly endemic areas of northeastern South Africa.

Benson Chuks Iweriebor1, Lufuno Grace Mavhandu, Tracy Masebe, David Rekosh, Marie-Louise Hammarskjold, Jeffrey M Mphahlele, Pascal Obong Bessong.   

Abstract

There is paucity of data on the genetic landscape of HIV-1 viruses circulating in the Limpopo Province of northeastern South Africa. Here, we examine the genetic diversity of viruses from Bela-Bela and Musina, two towns with high HIV prevalence. Between June 2007 and March 2008, blood samples were collected from antiretroviral-drug-naïve individuals. Viruses were analyzed for genetic subtypes and drug resistance mutations. All of the viruses in these samples were shown by phylogenetic analysis based on gag p17, gag p24, reverse transcriptase, protease and envelope C2-C3 gene regions to belong to HIV-1 subtype C. Two of 44 reverse transcriptase sequences (4.5%) contained N rather than the consensus K at position 103. The K103N mutation is normally associated with resistance to NNRTIs. No major mutations were observed in the protease gene. However, several polymorphisms and amino acid changes normally considered to be minor drug resistance mutations were observed in the protease sequences. These results suggest that HIV-1 subtype C remains the predominant variant responsible for the epidemic in northeastern South Africa and that the prevalence of drug-resistant viruses among the naïve population is low.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22189822      PMCID: PMC4957143          DOI: 10.1007/s00705-011-1180-z

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  41 in total

1.  HIV-1 Subtype A, D, G, AG and unclassified sequences identified in South Africa.

Authors:  Helba Bredell; Gillian Hunt; Alison Casteling; Tonie Cilliers; Celia Rademeyer; Mia Coetzer; Steven Miller; David Johnson; Caroline T Tiemessen; Desmond J Martin; Carolyn Williamson; Lynn Morris
Journal:  AIDS Res Hum Retroviruses       Date:  2002-06-10       Impact factor: 2.205

2.  Characterization of HIV type 1 genetic diversity among South African participants enrolled in the AIDS Vaccine Integrated Project (AVIP) study.

Authors:  Maria A Papathanasopoulos; Eftyhia Vardas; Carole Wallis; Richard Glashoff; Stefano Buttó; Guido Poli; Mauro Malnati; Mario Clerici; Barbara Ensoli
Journal:  AIDS Res Hum Retroviruses       Date:  2010-06       Impact factor: 2.205

3.  Characterization of human immunodeficiency virus type 1 from a previously unexplored region of South Africa with a high HIV prevalence.

Authors:  Pascal Obong Bessong; Chikwelu Larry Obi; Tonie Cilliers; Isaac Choge; Mary Phoswa; Candice Pillay; Maria Papathanasopoulos; Lynn Morris
Journal:  AIDS Res Hum Retroviruses       Date:  2005-01       Impact factor: 2.205

Review 4.  Impact of genetic diversity of HIV-1 on diagnosis, antiretroviral therapy & vaccine development.

Authors:  Renu B Lal; Sekhar Chakrabarti; Chunfu Yang
Journal:  Indian J Med Res       Date:  2005-04       Impact factor: 2.375

5.  Circulating recombinant form (CRF) 37_cpx: an old strain in Cameroon composed of diverse, genetically distant lineages of subtypes A and G.

Authors:  Rebecca L R Powell; Jiangqin Zhao; Frank A J Konings; Shixing Tang; Leonard Ewane; Sherri Burda; Mateusz M Urbanski; D R Saa; Indira Hewlett; Phillipe N Nyambi
Journal:  AIDS Res Hum Retroviruses       Date:  2007-07       Impact factor: 2.205

6.  HIV-1 subtype C reverse transcriptase sequences from drug-naive pregnant women in South Africa.

Authors:  Candice Pillay; Helba Bredell; James McIntyre; Glenda Gray; Lynn Morris
Journal:  AIDS Res Hum Retroviruses       Date:  2002-05-20       Impact factor: 2.205

Review 7.  Vaccines and vaccine strategies against HIV.

Authors:  Ivan Stratov; Robert DeRose; Damian F J Purcell; Stephen J Kent
Journal:  Curr Drug Targets       Date:  2004-01       Impact factor: 3.465

Review 8.  HIV-1 RNA dimerization: It takes two to tango.

Authors:  Michael D Moore; Wei Shau Hu
Journal:  AIDS Rev       Date:  2009 Apr-Jun       Impact factor: 2.500

9.  Comparison of phenotypic and genotypic tropism determination in triple-class-experienced HIV patients eligible for maraviroc treatment.

Authors:  Linos Vandekerckhove; Chris Verhofstede; Els Demecheleer; Stephane De Wit; Eric Florence; Katrien Fransen; Michel Moutschen; Wendy Mostmans; Kabamba Kabeya; Nicola Mackie; Jean Plum; Dolores Vaira; Kurt Van Baelen; Ina Vandenbroucke; Veerle Van Eygen; Herwig Van Marck; Dirk Vogelaers; Anna Maria Geretti; Lieven J Stuyver
Journal:  J Antimicrob Chemother       Date:  2010-12-31       Impact factor: 5.790

10.  Maraviroc in treatment-experienced patients with HIV-1 infection - experience from routine clinical practice.

Authors:  S Reuter; P Braken; B Jensen; S Sierra-Aragon; M Oette; M Balduin; R Kaiser; D Häussinger
Journal:  Eur J Med Res       Date:  2010-06-28       Impact factor: 2.175

View more
  4 in total

1.  Trends in Pretreatment HIV-1 Drug Resistance in Antiretroviral Therapy-naive Adults in South Africa, 2000-2016: A Pooled Sequence Analysis.

Authors:  Benjamin Chimukangara; Richard J Lessells; Soo-Yon Rhee; Jennifer Giandhari; Ayesha B M Kharsany; Kogieleum Naidoo; Lara Lewis; Cherie Cawood; David Khanyile; Kassahun A Ayalew; Karidia Diallo; Reshmi Samuel; Gillian Hunt; Alain Vandormael; Babill Stray-Pedersen; Michelle Gordon; Tariro Makadzange; Photini Kiepiela; Gita Ramjee; Johanna Ledwaba; Monalisa Kalimashe; Lynn Morris; Urvi M Parikh; John W Mellors; Robert W Shafer; David Katzenstein; Pravi Moodley; Ravindra K Gupta; Deenan Pillay; Salim S Abdool Karim; Tulio de Oliveira
Journal:  EClinicalMedicine       Date:  2019-03-18

2.  An affordable HIV-1 drug resistance monitoring method for resource limited settings.

Authors:  Justen Manasa; Siva Danaviah; Sureshnee Pillay; Prevashinee Padayachee; Hloniphile Mthiyane; Charity Mkhize; Richard John Lessells; Christopher Seebregts; Tobias F Rinke de Wit; Johannes Viljoen; David Katzenstein; Tulio De Oliveira
Journal:  J Vis Exp       Date:  2014-03-30       Impact factor: 1.355

Review 3.  Map of biomedical research in Cameroon; a documentary review of approved protocols from 1997 to 2012.

Authors:  Ebile Akoh Walter; Ateudjieu Jerome; Djuidje Ngounoue Marceline; Martin Ndinakie Yakum; Watcho Pierre
Journal:  Global Health       Date:  2017-11-21       Impact factor: 4.185

4.  Human immunodeficiency virus (HIV) type 1 genetic diversity in HIV positive individuals on antiretroviral therapy in a cross-sectional study conducted in Teso, Western Kenya.

Authors:  Maureen Adhiambo; Olipher Makwaga; Ferdinard Adungo; Humphrey Kimani; David Hughes Mulama; Jackson Cheruiyot Korir; Matilu Mwau
Journal:  Pan Afr Med J       Date:  2021-04-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.